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Background: Little is known about the use of traditional preparations for uterotonic effects at or near delivery
in Sub-Saharan Africa. Objective: To describe (1) use of traditional preparations in Sub-Saharan Africa
intended to have uterotonic effects at or near birth; and (2) results of pharmacologic investigations of the
uterotonic properties of such preparations. Search strategy: Structured review of 13 databases. Selection
criteria: Articles describing use of traditional preparations in Sub-Saharan Africa with primary data, published
in English between January 1, 1980 and June 30, 2010. Data collection and analysis: Full-text review using
standard spreadsheet templates. Main results: Objective 1 analysis identified 208 plant species used for
uterotonic effects at or near delivery. The most common use was labor induction/augmentation (n=185).
Other uses were to expel the placenta, shorten the third stage of labor, manage retained placenta (n=61),
and prevent/manage postpartum hemorrhage (n=20). Objective 2 analysis identified 82 species with
uterotonic activity confirmed through pharmacologic evaluation. Studies also identified potentiating/
inhibiting effects of extracts on pharmaceutical uterotonics. Conclusion: Numerous plants are used for
uterotonic effects in Sub-Saharan Africa; uterotonic activity has been confirmed in many through pharmaco-
logic evaluation. Such use may increase the risk of adverse outcomes. Further research is needed on the
uterotonic efficacy of traditional preparations and on interventions to address use during labor.
© 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Around 350 000 women die of maternal causes annually [1,2].
Most of these deaths occur in low-resource countries, and nearly
three-fifths in Sub-Saharan Africa [2]. The most common cause of ma-
ternal mortality in Sub-Saharan Africa is obstetric hemorrhage [3].
Most maternal deaths are preventable through access to emergency
obstetric care (EmOC) and evidence-based interventions such as ac-
tive management of the third stage of labor (AMTSL). AMTSL includes
administration of a pharmaceutical uterotonic (e.g. oxytocin or miso-
prostol) immediately following delivery to prevent postpartum hem-
orrhage (PPH) due to uterine atony [4,5].
As less than half of births in Sub-Saharan Africa are attended by
a skilled provider, universal access to interventions such as AMTSL
is low [6]. In this context, it is important for policies and programs
to consider the widespread use of traditional medicines in the re-
gion during pregnancy and delivery. Hospital-based studies in
South Africa have estimated that 43%–55% of women have used tra-
ditional preparations during pregnancy [7]. A South African study
found that 32% of pregnant women utilized traditional preparationseration of Gynecology and Obstetrics.known as imbelikisane to induce or augment labor [8]. A recent Nigerian
study found that 62% of surveyedwomen had utilized herbal medicines
during pregnancy [9]. High proportions of traditional birth attendants
(TBAs) provide herbal medications to women during pregnancy or at
or near delivery, including for intendeduterotonic effects [10–12]. Stud-
ies in Nigeria and Kenya documented that nearly 25% of TBAs utilized
herbal preparations to expel retained placenta [13,14]. The Kenya
study also noted that TBAs consider labor prolonged only after herbal
medicines to augment labor have failed [14].
The fact that traditional medicines may have uterotonic effects is
an important public health consideration [15]. A trial comparing a
Tibetan traditional product with misoprostol for PPH prevention
found that although misoprostol was more effective in reducing
PPH, the traditional product had uterotonic effects [16]. While
there may be potential for utilizing traditional preparations in PPH
prevention, their uterotonic effects can also have adverse conse-
quences, particularly if used to induce or accelerate labor. Studies
in Malawi and Uganda have suggested that traditional medicines
may be implicated in a substantial proportion of analyzed maternal
deaths [17,18]. Other studies have suggested that herbal medicines
are involved in adverse maternal and fetal outcomes such as uterine
rupture and meconium aspiration [19–22].
A number of studies have investigated the pharmacologic activity
of individual plants used at or near delivery. Resources such as thePublished by Elsevier Ireland Ltd. All rights reserved.
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for numerous indications [23] and some reviews have documented
plants used in traditional herbal mixtures taken during pregnancy
and at or near delivery [24,25].
However, the literature is lacking a systematic investigation of tra-
ditional preparations used for intended uterotonic effects at or near
time of delivery across Sub-Saharan Africa, as well as a systematic
documentation of findings of pharmacologic investigations of prepa-
rations taken for these purposes. Finally, much relevant anthropolog-
ical and ethnobotanical literature has not been organized and
targeted for a public health audience.
2. Review objectives
The present structured review was undertaken with 2 objectives:
(1) to describe the use of traditional preparations in Sub-Saharan
Africa intended to have uterotonic effects at or near birth including
inducing, augmenting, or speeding labor, or for preventing and
treating PPH; and (2) to describe the results of pharmacologic inves-
tigations of uterotonic properties of traditional preparations used in
Sub-Saharan Africa at or near time of delivery.
3. Materials and methods
A review of 13 medical, public health, and social sciences data-
bases was conducted, restricted to periodical literature published be-
tween January 1, 1980 and June 30, 2010. Databases included Scopus,
Global Health, Embase, JSTOR, CINAHL, PubMed, POPLINE, IndMED,
CSA Sociological Abstracts, Anthropology Plus, AnthroSource, Devel-
opment Experience Clearinghouse, and ProQuest Dissertations. The
journal Medical Anthropology was also reviewed. Search terms com-
bined words and phrases such as: home birth; traditional medicine;
pregnancy; herbal; uterotonic; oxytocic; postpartum; hemorrhage;
developing country; Africa; pregnancy outcome; labor (obstetric);
and delivery (obstetric). Searches were adapted to databases’ termi-
nology and topic categories.
Journal articles identified through searches were included based
on citation/abstract review if they were published in English within
the specified period, contained primary data, and discussed use of tra-
ditional preparations in Sub-Saharan Africa. Articles were excluded
based on citation/abstract review if they were review articles without
primary data, referred solely to hospital practices, or exclusively
addressed practices before 1980. Dissertations, conference publica-
tions, and books were excluded.
Articles meeting these criteria that could be located received
full-text review. During full-text review, articles were excluded
from analysis if exclusively describing:
• General classes of preparations (e.g. South Africa's isihlambezo and
imbelikisane) without identification of specific plants.
• Use of traditional preparations early in pregnancy or in prenatal
care, rather than at or near delivery.
• Use of traditional preparations for newborn care.
• Preparations that do not come into contact with the pregnant/
delivering woman's body, e.g. “buried at door.”
• Use of traditional preparations at or near delivery solely to prevent
or manage infections or pain.
• Use of preparations to prevent or treat postpartum bleeding due to
lacerations and other wounds (versus uterotonic mechanisms).
• Use of preparations derived from animal parts (few such prepara-
tions were identified, e.g. pangolin and sheep placenta).
For Objective 1, articles were also excluded if they were exclusive-
ly zoological or veterinary in focus, or described use of traditional
preparations solely to prevent spontaneous abortion, induce abortion,
or address menstrual disorders. For Objective 1 analysis, all plants
with intended uterotonic effects were classified as used for one ormore of the following indications: induce or augment labor; expel
placenta or manage retained placenta; prevent or treat PPH; induce
“oxytocic effect” without specification; induce another effect that
may be uterotonic (e.g. “expel dead fetus”); and promote general
maternal/fetal health.
Articles related to Objective 2 were excluded if they only conducted
phytochemical or toxicity screening to identify constituents without
testing of uterotonic activity. Articles related to Objective 2 were in-
cluded even if their primary focus was preparations believed to have
contraceptive or abortifacient effects, as long as uterotonic activity
was evaluated. For Objective 2 analysis, 3 indication classifications
were added: abortifacient, antifertility/contraceptive, and menstrual
disorders. All included articles were abstracted using standard
spreadsheet templates.
4. Results
4.1. Overview
Supplementary Material S1 (online only) provides a review flow
diagram. Based on the search strategy, 12 076 non-duplicative refer-
ences were identified. This large number resulted from using general
search terms such as “traditional medicine” to ensure that relevant
articles were not omitted. Inclusion and exclusion criteria were ap-
plied to these citations/abstracts leaving 271 references for full-text
review. Of these, 187 met Objective 1 and 84 met Objective 2. If
an article was included in the analysis following full-text review,
inclusion and exclusion criteria were also applied to its bibliogra-
phy, generating additional references for full-text review. Following
full-text review of all relevant resources, 48 articles were included
in Objective 1 analysis, and 54 articles were included in Objective
2 analysis. One study was included in both analyses because it gath-
ered primary data regarding herbal agent use and conducted phar-
macologic evaluations of identified plants [26]. Supplementary
Material S2 (online only) lists all of the references included in the
Objective 1 and Objective 2 analyses.
A number of articles with relevant content were not included
owing to publication earlier than the inclusion period. The oldest
identified resource documenting uterotonic effects of traditionally
used plants was published in 1915, indicating that there has been
awareness of the potential uterotonic activity of traditional medicines
for much of the past century. Over 50 identified articles described use
of traditional preparations during pregnancy in Sub-Saharan African
countries (particularly Ghana and Nigeria) including for uterotonic
purposes, but were excluded owing to absence of information about
the specific plants utilized. Similarly, several studies were excluded
because they documented the use of herbal mixtures (e.g. sunungure
in Zimbabwe) to induce or augment labor without noting the specific
plants used [27–29].
Many resources included in the analysis were published in
journals from low-resource countries. This may partly be owing to
the greater recognition of traditional medicine in these countries, in-
cluding formal establishment of Centers for Traditional Medicine
within Ministries of Health (e.g. in South Africa and Tanzania) as
well as at the World Health Organization (e.g. The Collaborating
Center for Traditional Medicine).
4.2. Objective 1 results
The 48 articles included in the Objective 1 analysis described usage
of traditional uterotonics in 13 countries (Table 1). Themost frequent-
ly studied countries were Tanzania (n=12), Ethiopia (n=9), and
South Africa and Uganda (n=7 each). Researchers interviewed tradi-
tional healers/herbalists (30 studies), general community members
(12 studies), TBAs or other traditional midwives (10 studies),
women (6 studies), and elders (4 studies). Sample sizes ranged from
Table 1
Objective 1: Studies documenting the use of traditional preparations for intended uterotonic effects.
Country (No. of studies) First author Year Primary population (Sampled or described)
Cameroon (1) Noumi E 2001 Community members, herbalists, traditional healers
Ethiopia (9) Balemie K 2004 Traditional healers, elders
Bekalo TH 2009 Male and female elders
Giday M 2003 Elders (primarily male)
2007 Traditional healers, farmers
2009a Male and female community members
2009b Male and female community members
Jahn SAA 1991 Community members
Lukelal E 2008 Knowledgeable individuals, traditional healers
Wondimu T 2007 Community members
Gambia (1) bij de Vaate 2002 Traditional birth attendants (TBAs)
Guinea (1) Akendengue B 1992 Traditional healers
Kenya (3) Morgan WTW 1981 Community members
Nayningi MO 2008 Community members, traditional healers
Voorhoeve AM 1982 Pregnant/recently delivered women
Malawi (1) Bullough CHW 1982 TBAs
Nigeria (2) Egwuatu VE 1986 Pregnant/delivering women, TBAs, traditional healers
Irinoye OO, 2001 TBAs
Sierra Leone (1) Lebbie AR 1995 Herbalists
Somalia (2) Samuelsson G 1991 Traditional healers
1992 Traditional healers
South Africa (7) Arnold HJ 1984 Traditional healers
Brindley M 1985 Elders (female)
Jepson AP 1988 TBAs
Selepe HL 2000 TBAs (including isangomas)
Troskie TR 1997 Traditional healers/midwives, health providers
van der Kooi R 2006 Pregnant women, health professionals, traditional healers
Varga CA 1997 Women, traditional healers
Tanzania (12) Chhabra SC 1987 Traditional healers
1989 Traditional healers
1990 Traditional healers
1991 Traditional healers
1993 Traditional healers
Hedberg I 1982 Traditional healers
1983a Traditional healers
1983b Traditional healers
Mahonge CPI 2006 Traditional midwives, traditional healers
Maregesi SM 2007 Herbalists
Mbura JS 1985 Antenatal care clients
Ramathal DC 2001 Herbalists (among Rwandan and Burundian refugees)
Uganda (7) Hamill FA 2000 Herbalists
2003 Herbalists
Kakudidi EK 2000 Community members
Kamatenesi-Mugisha M 2007 Traditional healers/herbalists, TBAs, community members, women
Oryem-Origa H 2003 Community members
Ssegawa P 2007 Community members, traditional healers
Tabuti JR 2003 Community members, traditional healers
Zimbabwe (1) Tumwine JK 1991 TBAs
18 V. Tripathi et al. / International Journal of Gynecology and Obstetrics 120 (2013) 16–22interviews with 7 TBAs [30] to a survey of 2200 recently-delivered
women [31].
Included articles were published in public health, anthropological,
and ethnobotanical journals. Public health articles often described
traditional uterotonics in the context of efforts to train TBAs, under-
stand TBA practices, or scale up use of skilled care at delivery. Some
described traditional uterotonics in the context of research on
presenting conditions at health facilities (including due to liver/
kidney toxicity). Anthropological articles tended to discuss tradi-
tional uterotonics in the context of describing a particular culture's
birth beliefs and customs or medical and religious practices. Ethno-
botanical articles tended to mention traditional uterotonics in the
context of documenting the traditional pharmacopeia across all
medicinal purposes for specific tribes or in specific geographic
areas (e.g. near parks or preserves), rather than targeting obstetric
or reproductive indications. Owing to this variety of aims, included
articles ranged from a study identifying 1 plant used to treat retained
placenta out of 78 medicinal plants used by Kerreyua pastoralists in
Ethiopia, to a study documenting 75 plants used to induce labor in
just 2 districts of Uganda [32,33].Interviews, guided field walks (including in ecologically fragile
areas), or other systematic data collection approaches with traditional
healers, elders, or men andwomen in communities of focus were used
to identify plants. Descriptions of indications for use varied widely,
and interview questions were not standardized across disciplines,
countries, or investigation teams. As a result, stated indications re-
quired interpretation to determine whether they matched inclusion
criteria. For example, the phrase “to ease delivery” might refer to
pain relief and/or to accelerating labor. Many plants were perceived
to have both uterotonic and non-uterotonic roles in labor and delivery
(e.g. promoting good fetal or maternal outcomes).
The most common indications for use were to induce or augment
labor, including in cases of prolonged labor or overdue pregnancy
(185 plants). An additional 17 plants were described as being used
for similar indications, such as to “relax” or “widen” the pelvis for
delivery, or facilitate delivery. Sixty-one plants were described as
being used to expel the placenta, shorten the third stage of labor,
or manage retained placenta. Twenty plants were described as
being used for PPH prevention or management, including indica-
tions such as “promoting tone” after delivery or “preventing
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“general oxytocic effects” without specification, and 2 plants were
described as used for other purposes that appear to be uterotonic
(expel dead fetus and promote flow of lochia). The route of adminis-
tration was primarily oral, with some topical administration and
some venting of smoke/vapors into the vagina. Most oral prepara-
tions were infusions or decoctions, although in some cases the
plant part (e.g. leaves) was eaten directly. The most commonly
used plant parts were leaves, roots, bark and stems, and fruit.
Supplementary Material S3 Table 1 (online only) lists identified
traditional preparations by species name and intended effects, and
Supplementary Material S3 Table 2 (online only) provides additional
information by each included study, including country of use, indica-
tions for traditional use, and routes of administration. A total of 208
plants were identified using primary data published between 1980
and 2010 as traditionally used for perceived uterotonic effect at or
near delivery. An additional 19 plants were described by local or ver-
nacular terms, without scientific names. Plants were generally identi-
fied in 1–2 studies; however, some plants were identified multiple
times, with Bidens pilosa and Cissampelos mucronata identified most
frequently (5 and 4 studies each). Several plants were used in multi-
ple countries; for example, Cissampelos mucronata was identified in
studies from 3 countries, but with varied indications for use. In Ugan-
da, it was used for inducing labor and expelling the placenta, whereas
in Ethiopia it was used for managing retained placenta. Similarly, in a
2007 study, Giday et al. [34] identified 4 plants traditionally used by
the Shinasha, Agew-awi, and Amhara to manage bleeding after deliv-
ery, but no plants for other uterotonic indications. In 2009, the same
lead researcher identified 6 plants traditionally used by the Meinit
people to manage retained placenta, but no plants for other
uterotonic indications [35]. It is unclear if these patterns are an arti-
fact of data collection methodology or represent differences in cultur-
al knowledge and perceptions regarding medicinal plants or the
severity and amenability to treatment of different conditions.
Few papers included descriptions of pregnant women obtaining
plants and compounding traditional medicines themselves. Very
few articles provided information on dosage beyond frequency of
administration.4.3. Objective 2 results
The 54 articles included in the Objective 2 analysis described anal-
ysis of the uterotonic activity of plant species whose use was primar-
ily described in 10 countries (with reference to additional use in
Burundi, Congo, and Congo-Brazzaville). Table 2 summarizes the
key evaluations conducted in each study. The most frequent focus
countries were Nigeria (n=22) and South Africa (n=18); several
studies also evaluated plants used in Ethiopia. As illustrated in Sup-
plementary Material S3 Table 3 (online only), 81 plant species dem-
onstrated uterotonic activity during in vitro pharmacologic
evaluation. One study confirmed increase in in vivo oxytocin release
following exposure to another plant extract (Sida veronicaefolia),
but did not evaluate in vitro effects. One study confirmed uterotonic
activity in a plant identified only by its local name.
Included articles evaluated between 1 and 70 plants for uterotonic
activity. Articles were included in the Objective 2 analysis even if the
studied plant's primary traditional use was as an abortifacient or an-
tifertility agent, as long as uterotonic activity was assessed in a phar-
macologic evaluation. The most frequent traditional uses of plants
evaluated in studies included in the Objective 2 analysis were to in-
duce/augment labor (n=54), expel retained placenta (n=18), and
cause abortion (n=14). A large number of plants were also used for
antifertility purposes (n=44), largely owing to inclusion of a study
by Desta [36] of 70 plants traditionally used for this reason. Plants
whose uterotonic activity was confirmed in 3 or more studiesincluded: Agapanthus africanus, Clivia miniata, Gunnera perpensa,
Monechma ciliatum, Rhoicissus tridentata, and Spondias mombin.
Studies varied widely in the details provided about experimental
methodology (e.g. number of tissue samples, measures of contractile
activity, dosages). However, in general, uterotonic activity was evalu-
ated through in vitro experiments measuring effects of plant ex-
tracts and/or reference pharmaceutical drugs (e.g. acetylcholine)
on isolated uterine tissue strips, generally from rats or guinea pigs.
Most frequently, uterine strips were obtained from virgin rats or
guinea pigs that had been administered stilbestrol or other estrogen
18–48 hours before being killed. Some investigations also used uter-
ine tissue from gravid animals. Two studies evaluated the effect of
pretreatment with the extract before the study animal was killed.
Tissue strips were mounted in an aerated bath of Tyrode, de Jalon,
or similar solution. Contractions were generally measured using
force-displacement transducers and polygraph-type writing devices.
Some studies used aqueous extracts to mimic traditional prepara-
tions, while others utilized alcohol extracts.
While all included articles evaluated changes in contractile activi-
ty, studies varied in defining such activity, choosing to focus on
changes in frequency, amplitude, force, and/or tone, either in refer-
ence to spontaneous contractions or compared with a standard
pharmaceutical drug's effects. Dose–response curves were generally
constructed for each extract or drug tested.
As summarized in Table 2, 41 studies evaluated the potentiating or
inhibitory effects of the extract when introduced in conjunction with
other receptor-specific pharmaceutical agonists (e.g. acetylcholine)
or antagonists (e.g. atropine). The most commonly proposed mecha-
nisms of action for plants' in vitro uterotonic effects were mediation
through cholinergic receptors, often muscarinic receptors, or promo-
tion of prostaglandin synthesis. A number of studies simply charac-
terized uterotonic activity as being similar or different in profile to
oxytocin or ergometrine. In 19 studies, the ability of plant extracts
to inhibit or potentiate contractile responses to pharmaceutical
uterotonics was specifically evaluated, with potentiating effects on
oxytocin responses frequently confirmed. Eighteen studies identified
plant extract constituents (e.g. through phytochemical screening)
and 6 conducted acute toxicity assessments (e.g. LD50 tests). For
plants whose primary traditional use was as an abortifacient or con-
traceptive, studies also included evaluations of in vivo estrogenic/
uterotrophic (n=5), anti-implantation (n=5), and/or abortifacient
effects (n=8).
Some studies identified variation in uterotonic activity within spe-
cies, comparing extracts from plants harvested in different seasons,
different parts of the same plant (e.g. roots versus seeds), or plants
stored for different lengths of time (1 month versus 1 year). Katsoulis
[37] and Katsoulis et al. [38] noted that few users or providers of tra-
ditional preparations appear to be aware of such variation.
5. Discussion
There is widespread use of traditional medicines at or near deliv-
ery in Sub-Saharan Africa. A wide variety of plants is used for per-
ceived uterotonic effects, including to induce or augment labor,
expel retained placenta, and manage postpartum bleeding. While
some plants have been described as being used for uterotonic indica-
tions across borders, different regions and countries appear to have
non-overlapping pharmacopeias. Many plants traditionally used to
induce and augment labor demonstrate uterotonic activity during in
vitro evaluations of their direct contractile effect.
Clinically, use of traditional uterotonic agents to augment labor
may indicate an underlying labor disorder that is not amenable to
herbal treatment. Additionally, uterotonic agents can lead to uterine
hyperstimulation, fetal asphyxia, and other adverse outcomes [39]. Fi-
nally, as the use of pharmaceutical uterotonics during labor increases
PPH risk, it is plausible that the more potent traditional preparations
Table 2
Objective 2: Studies conducting pharmacologic evaluation of traditional preparations.a
Primary country
(No. of studies)
First author Year Evaluated effects on response
to pharmaceutical uterotonics
Evaluated effects in presence of
reference agonists and antagonists
Toxicity screening/
LD50 test
ID of
constituents
Cameroon (2) Frida L 2008 - +b + -
Kamanyi A 1992 - + - -
Cote d'Ivoire (2) Datte J 1996 - + - -
Zihiri GN 1996 - + - -
Ethiopia (4) Desta B 1994 - - - -
Gebrie E 2005 - + - -
Mekonnen Y 1999 - + - -
Tafesse G 2006 - + - -
Ghana (1) Lutterodt GDc 1995 - - - -
Kenya (2) Osore H 1982 - + - -
Sinei KA 1995 - - - -
Malawi (1) Bullough CHW 1982 - - - -
Nigeria (22) Aguwa CN 1987 - + + +
Akah PA 1994 + - + +
Bafor EE 2009a +d + - +
2009b - - - -
2010 - + - -
Falodun A 2006 + + - +
Ie O 2008 + + - +
Ladeji O 2005 + + - +
Nwodo OFC 1983 - + - +e
1988 - + - -
1991 +f - - -
Nworu CS 2007 + + + +
Oden Odu U 1995 - - - -
Offiah VN 1989 + + + +
Ojewole AJO 1982 - + - -
Okwusaba SCg 1997 + + - -
Onuaguluchi G 1999 - + - -
Owolabi OJ 2010 + + - -
Udoh FV 1999 + - + +
Uguru MO 1995 + + - -
1998 +h + - -
1999 - - - +
South Africa (18) Brookes KB 1999 - + - +
2006 - + - +
2007 - + - +
Kaido TL 1997 + - - -i
Katsoulis LC 1999 - + - -
2000 - + - -
2002 - + - -
Khan F 2004 - + - +
Mahomed IM 2006 + + - -
Mulholland DA 2002 - + - +
Sewram V 1998 - + - -
2000 - + - +
2001 - + - +
Veale DJH 1989 + + - -
1990 + + - -
1999 + + - -
2000 -j + - -
2001 - - - -
Sudan (1) Mohamed A-EH 1990 - + - -k
Uganda (1) Kamatenesi-Mugisha M 2007 + - - -
a All articles included in the Objective 2 analysis documented that plant extracts produced some direct increase in contractile activity (e.g. increased frequency or amplitude of
contractions), either in absolute terms or compared with reference pharmaceutical drugs.
b Evaluation of contractile activity in presence and absence of reference pharmaceutical noted, but results not explicitly described.
c This study evaluated the effect of the extract on in vivo oxytocin release.
d Refers to previous unpublished research documenting extract's inhibiting effect on oxytocin responses.
e Extracts partially analyzed for likely composition.
f Prostaglandin E2 administered in presence of plant extract and reference antagonist.
g In this study, the extract was administered to living rats, and uterine contractile activity in the presence of pharmaceutical uterotonics and other reference agonists/antagonists
was evaluated in vitro after the animals were killed.
h Effects of oxytocin and other pharmaceutical uterotonics evaluated after in vivo pretreatment of study animals with plant extracts.
i Evaluation of concentrations of Na+, K+, and Ca++ extract solutions.
j Refers to previous studies evaluating potentiating effect of plant extracts on oxytocin.
k Fractions isolated, but constituents not identified.
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potentiate the effects of pharmaceutical uterotonics and may have
implications for dosing of oxytocin and other pharmaceuticals in
clinical management.However, the fact that some traditional preparations may be potent
uterotonics also provides an opportunity for further research. Plant
preparations may be useful in PPH prevention, particularly in settings
where use of pharmaceutical uterotonics is not feasible. While there
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method, storage, and season, there is potential for national centers for
study of traditional medicine to support development and standardiza-
tion of effective, safe uterotonic products based on locally available plant
materials. Additional research is needed to identify active agents in
potent plants, determine mechanisms of action, and identify toxicities.
Three important implications for public health programs and
research emerge from these findings. First, many plants traditionally
used at or near the time of delivery have not yet been evaluated for
uterotonic activity. The present review documents the use of tradi-
tional uterotonic agents in at least 19 countries, and over 270 plants
with perceived or confirmed uterotonic effects. However, just 17 of
these plants were discussed in studies included in both the Objective
1 and Objective 2 analyses. Uterotonic activity was confirmed in 82
plant species, but only a fraction of those identified as traditionally
used for uterotonic indications. Additional research is needed re-
garding the uterotonic activity of plants traditionally used at or
near the time of delivery and their mechanisms of action. The chang-
ing uterine sensitivity to oxytocin and other compounds later in
pregnancy also necessitates study of potency on gravid uterine tissue
as opposed to estrogen-primed tissue, which may manifest different
responses to uterotonic compounds. It may also be useful to priori-
tize further in-depth research on the 6 plants whose uterotonic ac-
tivity has been confirmed in multiple studies.
Second, much research on usage of traditional preparations for
uterotonic indications was published during the 1980s and 1990s,
when TBA training programs were widespread. Relatively few studies
in the review were published in the last decade, during which TBA
training has been discouraged by the international community [40].
Understanding current patterns of traditional uterotonic usage in
light of increased access to pharmaceuticals for PPH prevention and
treatment in Sub-Saharan Africa is also needed. Exposure to plants
whose uterotonic activity is mediated through related mechanisms
of actionmay interferewith or amplify the effects of these pharmaceu-
ticals. Targeted research on traditional preparation use, including dos-
age and preparation practices, may be particularly important in
Sub-Saharan African countries with high PPH-related mortality. With
the more specific information now available on the uterotonic activity
of herbal agents, investigations of near-miss and verbal autopsies on
maternal mortality cases involving uterine rupture and stillbirth can
be more complete. Similar research and investigations are needed in
other settingswhere use of traditionalmedicines remains high and ac-
cess to skilled care at delivery is low, such as parts of South Asia.
Finally, in settings where traditional preparations are commonly
used for induction or augmentation of labor and have been shown
to be potent uterotonics, this practice may be implicated in adverse
outcomes such as uterine rupture and fetal asphyxiation. Maternal
and newborn health programs may need to develop appropriate
health education and behavior change messages to discourage such
use. Formative research may be needed to identify the best way to de-
velop and disseminate such messages. Given that induction and aug-
mentation of labor are by far the most commonly cited uses for
uterotonic preparations, there appears to be strong belief that tradi-
tional preparations are necessary to have appropriate labor or con-
tractions. It is important to understand these beliefs to determine
whether behavior modification (e.g. encouraging use of preparations
only after delivery of the infant) can be promoted. Provider training
may be needed to ensure that clinicians are aware of the local use
of herbal uterotonics and obtain a history of such use from patients
to inform clinical management decisions.
Acknowledgments
Funding for this literature review was provided through contract
# GAT 1429-07882-SUB via the Oxytocin Initiative at PATH with
funding from the Bill & Melinda Gates Foundation.Conflict of interest
The authors have no conflict of interest.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ijgo.2012.06.020.References
[1] Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, et al. Maternal
mortality for 181 countries, 1980–2008: a systematic analysis of progress towards
Millennium Development Goal 5. Lancet 2010;375(9726):1609-23.
[2] World Health Organization. Trends in Maternal Mortality: 1990 to 2008. Esti-
mates developed by WHO, UNICEF, UNFPA, The World Bank. whqlibdoc.who.
int/publications/2010/9789241500265_eng.pdf. Published 2010.
[3] Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes
of maternal death: a systematic review. Lancet 2006;367(9516):1066-74.
[4] Begley CM, Gyte GM, Murphy DJ, Devane D, McDonald SJ, McGuire W. Active
versus expectant management for women in the third stage of labour. Cochrane
Database Syst Rev 2010(7):CD007412.
[5] PrendivilleWJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active
versus physiological management of third stage of labour. BMJ 1988;297(6659):
1295-300.
[6] World Health Organization, Department of Reproductive Health and Research.
Proportion of births attended by a skilled health worker 2008 updates. www.
who.int/reproductivehealth/publications/maternal_perinatal_health/
2008_skilled_attendant.pdf. Published 2008.
[7] Mabina MH, Pitsoe SB, Moodley J. The effect of traditional herbal medicines on
pregnancy outcome. The King Edward VIII Hospital experience. S Afr Med J
1997;87(8):1008-10.
[8] O'Mahony D, Steinberg M. A population-based survey of obstetric practices
among rural women in the Bizana district, Transkei. S Afr Med J 1995;85(11):
1168-71.
[9] Olusanya BO, Alakija OP, Inem VA. Non-uptake of facility-based maternity
services in an inner-city community in Lagos, Nigeria: an observational study.
J Biosoc Sci 2010;42(3):341-58.
[10] Boerma JT, Baya MS. Maternal and child health in an ethnomedical perspective:
traditional and modern medicine in coastal Kenya. Health Policy Plan 1990;5(4):
347-57.
[11] Eades CA, Brace C, Osei L, LaGuardia KD. Traditional birth attendants and maternal
mortality in Ghana. Soc Sci Med 1993;36(11):1503-7.
[12] Sindiga I. Towards the participation of traditional birth attendants in primary
health care in Kenya. East Afr Med J 1995;72(7):459-64.
[13] Sogunro GO. Traditional obstetrics; a Nigerian experience of a traditional birth
attendant training program. Int J Gynecol Obstet 1987;25(5):375-9.
[14] Solomon MM, Rogo KO. A needs assessment study of traditional birth attendants
in rural Kenya. Int J Gynecol Obstet 1989;30(4):329-34.
[15] Flandermeyer D, Stanton C, Armbruster D. Uterotonic use at home births in
low-income countries: a literature review. Int J Gynecol Obstet 2010;108(3):
269-75.
[16] Miller S, Tudor C, Thorsten V, Nyima, Kalyang, Sonam, et al. Randomized double
masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol
to prevent postpartum hemorrhage in Lhasa, Tibet. J Midwifery Womens Health
2009;54(2):133-141.e1.
[17] Kongnyuy EJ, Mlava G, van den Broek N. Facility-based maternal death review in
three districts in the central region of Malawi: an analysis of causes and charac-
teristics of maternal deaths. Womens Health Issues 2009;19(1):14-20.
[18] Mbonye AK. Risk factors associated with maternal deaths in health units in
Uganda. Afr J Reprod Health 2001;5(3):47-53.
[19] Bullough CH. Analysis of maternal deaths in the Central Region of Malawi. East Afr
Med J 1981;58(1):25-36.
[20] Umeora OU, Egwuatu VE. The role of unorthodox and traditional birth care in ma-
ternal mortality. Trop Doct 2010;40(1):13-7.
[21] Gennaro S, Dugyi E, Doud JM, Kershbaumer R. Health promotion for childbearing
women in Rubanda, Uganda. J Perinat Neonatal Nurs 2002;16(3):39-50.
[22] Katsoulis LC, Veale DJ, Havlik I. The pharmacological action of Rhoicissus
tridentata on isolated rat uterus and ileum. Phytother Res 2000;14(6):460-2.
[23] Metafro Prelude Medicinal Plants Database. http://www.metafro.be/prelude/
plant_collection.
[24] Veale DJ, Furman KI, Oliver DW. South African traditional herbal medicines used
during pregnancy and childbirth. J Ethnopharmacol 1992;36(3):185-91.
[25] Gruber CW, O'Brien M. Uterotonic plants and their bioactive constituents. Planta
Med 2011;77(3):207-20.
[26] Bullough CH, Leary WP. Herbal medicines used by traditional birth attendants in
Malaŵi. Trop Geogr Med 1982;34(1):81-5.
[27] Sparks BT. A descriptive study of the changing roles and practices of traditional
birth attendants in Zimbabwe. J Nurse Midwifery 1990;35(3):150-61.
[28] Larsen JV, Msane CL, Monkhe MC. The Zulu traditional birth attendant. An evalu-
ation of her attitudes and techniques and their implications for health education.
S Afr Med J 1983;63(14):540-2.
22 V. Tripathi et al. / International Journal of Gynecology and Obstetrics 120 (2013) 16–22[29] Mutambirwa J. Pregnancy, childbirth, mother and child care among the indige-
nous people of Zimbabwe. Int J Gynecol Obstet 1985;23(4):275-85.
[30] Selepe HL, Thomas DJ. The beliefs and practices of traditional birth attendants in
the Manxili area of KwaZulu, South Africa: a qualitative study. J Transcult Nurs
2000;11(2):96–101.
[31] Voorhoeve AM, Kars C, van Ginneken JK. Machakos project studies. Agents affecting
health of mother and child in a rural area of Kenya. XXI. Antenatal and delivery care.
Trop Geogr Med 1982;34(1):91–101.
[32] Balemie K, Kelbessa E, Zemede Z. Indigenous medicinal utilization, management
and threats in Fentale Area, Eastern Shewa, Ethiopia. Ethiop J Biol Sci 2004;3(1):
37-58.
[33] Kamatenesi-Mugisha M, Oryem-Origa H. Medicinal plants used to induce labour
during childbirth in western Uganda. J Ethnopharmacol 2007;109(1):1-9.
[34] Giday M, Teklehaymanot T, Animut A, Mekonnen Y. Medicinal plants of the
Shinasha, Agew-awi and Amhara peoples in northwest Ethiopia. J Ethnopharmacol
2007;110(3):516-25.[35] Giday M, Asfaw Z, Woldu Z. Medicinal plants of the Meinit ethnic group of
Ethiopia: an ethnobotanical study. J Ethnopharmacol 2009;124(3):513-21.
[36] Desta B. Ethiopian traditional herbal drugs. Part III: Anti-fertility activity of 70
medicinal plants. J Ethnopharmacol 1994;44(3):199-209.
[37] Katsoulis LC. Rhoicissus tridentata subsp. cuneifolia: the effect of geographical
distribution and plant storage on rat uterine contractile activity. S Afr J Bot
1999;65(4):299-302.
[38] Katsoulis LC, Veale DJ, Havlik I. Seasonal variation in uterotonic activity of
Rhoicissus tridentata extracts. S Afr Med J 2002;92(5):375-7.
[39] James DK. High Risk Pregnancy: Management Options. 3rd edition.Philadelphia:
Saunders; 2006.
[40] Sibley LM, Sipe TA. Transition to skilled birth attendance: is there a future role for
trained traditional birth attendants? J Health Popul Nutr 2006;24(4):472-8.
